"Deprescriptions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Directions written to discontinue use of PRESCRIPTION DRUGS in order to reduce unnecessary and/or excessive medications (see POLYPHARMACY), DRUG SIDE EFFECTS and ADVERSE DRUG REACTION.
| Descriptor ID |
D000069340
|
| MeSH Number(s) |
E02.319.698.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Deprescriptions".
Below are MeSH descriptors whose meaning is more specific than "Deprescriptions".
This graph shows the total number of publications written about "Deprescriptions" by people in this website by year, and whether "Deprescriptions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 7 | 0 | 7 |
| 2016 | 20 | 7 | 27 |
| 2017 | 32 | 12 | 44 |
| 2018 | 28 | 11 | 39 |
| 2019 | 16 | 3 | 19 |
| 2020 | 7 | 13 | 20 |
To return to the timeline, click here.
Below are the most recent publications written about "Deprescriptions" by people in Profiles.
-
Managing rheumatic diseases during COVID-19. Clin Rheumatol. 2020 Nov; 39(11):3245-3254.
-
Managing rheumatoid arthritis during COVID-19. Clin Rheumatol. 2020 Nov; 39(11):3237-3244.
-
Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt. Rheumatol Int. 2020 Oct; 40(10):1599-1611.
-
Weaning From Exogenous Sedation in the Era of COVID-19 Infection: Recommendations for Sedation and Its Discontinuation. Prim Care Companion CNS Disord. 2020 Jul 16; 22(4).
-
Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19). Transpl Infect Dis. 2020 Aug; 22(4):e13286.
-
Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission. Rheumatology (Oxford). 2020 07 01; 59(7):1591-1598.
-
COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults. J Am Geriatr Soc. 2020 Aug; 68(8):1636-1646.
-
Keeping standards of multiple sclerosis care through the COVID-19 pandemic. Mult Scler. 2020 09; 26(10):1153-1156.
-
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab. Clin Rheumatol. 2020 Sep; 39(9):2797-2802.
-
Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis. Mult Scler Relat Disord. 2020 07; 42:102259.